TIGIT and neoplasm: In addition to the blocking effect of the two monospecific antibodies, bsAbs can connect immune cells to tumor cells and enhance cross-talk between TIGIT+ T cells and PD-L1+FcRs+ DCs, which further promoted anti-tumor activity [72].